Search research articles
Contact Us
Filters
Showing results (31-40 of 69) with videos related to
Page
of 7
Sort By:
Atherosclerosis. Supplements
|
November 4, 2017
Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes
Bernd Hohenstein, Ulrich Julius, Peter Lansberg, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis
Juergen Graessler, Kai Schuhmann, Andrej Shevchenko, et al.
Atherosclerosis. Supplements
|
December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis
Reinhard Klingel, Franz Heigl, Volker Schettler, et al.
Journal of Clinical Lipidology
|
November 25, 2019
Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study
Seth J Baum, Tiziana Sampietro, Dev Datta, et al.
Clinical Kidney Journal
|
January 28, 2025
First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors
Moritz Schanz, Claudia Seikrit, Bernd Hohenstein, et al.
Journal of the American Society of Nephrology : JASN
|
October 11, 2015
Extrarenal Progenitor Cells Do Not Contribute to Renal Endothelial Repair
Jan Sradnick, Song Rong, Anika Luedemann, et al.
Journal of the American Society of Nephrology : JASN
|
January 12, 2007
P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis
Bernd Hohenstein, Sindy Renk, Kathrin Lang, et al.
Atherosclerosis. Supplements
|
December 11, 2019
Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans
Natalia Jarzebska, Sophia Georgi, Normund Jabs, et al.
Journal of the American Society of Nephrology : JASN
|
March 4, 2005
Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis
Bernd Hohenstein, Laura Kasperek, Dieter-Johannes Kobelt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 22, 2021
Solid organ transplantation is not a risk factor for COVID-19 disease outcome
Christian Hugo, Melanie Stecher, Sebastian Dolff, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 69) with videos related to
Sort By:
Page
of 7
Atherosclerosis. Supplements
|
November 4, 2017
Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes
Bernd Hohenstein, Ulrich Julius, Peter Lansberg, et al.
Atherosclerosis. Supplements
|
May 5, 2015
Increasing plasma lysophosphatidylcholine levels in patients with regular dextran sulfate lipoprotein apheresis
Juergen Graessler, Kai Schuhmann, Andrej Shevchenko, et al.
Atherosclerosis. Supplements
|
December 11, 2019
Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis
Reinhard Klingel, Franz Heigl, Volker Schettler, et al.
Journal of Clinical Lipidology
|
November 25, 2019
Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study
Seth J Baum, Tiziana Sampietro, Dev Datta, et al.
Clinical Kidney Journal
|
January 28, 2025
First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors
Moritz Schanz, Claudia Seikrit, Bernd Hohenstein, et al.
Journal of the American Society of Nephrology : JASN
|
October 11, 2015
Extrarenal Progenitor Cells Do Not Contribute to Renal Endothelial Repair
Jan Sradnick, Song Rong, Anika Luedemann, et al.
Journal of the American Society of Nephrology : JASN
|
January 12, 2007
P2Y1 gene deficiency protects from renal disease progression and capillary rarefaction during passive crescentic glomerulonephritis
Bernd Hohenstein, Sindy Renk, Kathrin Lang, et al.
Atherosclerosis. Supplements
|
December 11, 2019
Kidney and liver are the main organs of expression of a key metabolic enzyme alanine:glyoxylate aminotransferase 2 in humans
Natalia Jarzebska, Sophia Georgi, Normund Jabs, et al.
Journal of the American Society of Nephrology : JASN
|
March 4, 2005
Vasodilator-stimulated phosphoprotein-deficient mice demonstrate increased platelet activation but improved renal endothelial preservation and regeneration in passive nephrotoxic nephritis
Bernd Hohenstein, Laura Kasperek, Dieter-Johannes Kobelt, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
February 22, 2021
Solid organ transplantation is not a risk factor for COVID-19 disease outcome
Christian Hugo, Melanie Stecher, Sebastian Dolff, et al.
Page
of 7